Financial Statements Notes to the Financial Statements vi Fair value of financial assets and financial liabilities Financial assets and financial liabilities are either carried in the Statement of Financial Position at their fair value investments and derivatives or the Statement of Financial Position amount is a reasonable approximation of fair value due from brokers, dividends and interest receivable, due to brokers, accrual, cash at bank, bank overdraft and amounts due under the loan facility.
vii Hierarchy of investments The Company has classified its financial assets designated at fair value through profit or loss and the fair value of derivative financial instruments using a fair value hierarchy that reflects the significance of the inputs used in making the fair value measurements.
The hierarchy has the following levels: Level 1 quoted prices unadjusted in active markets for identical assets or liabilities: Level 2 inputs other than quoted prices included with Level 1 that are observable for the asset or liability, either directly i. e. as prices or indirectly i. e. derived from prices : and Level 3 inputs for the asset or liability that are not based on observable market data unobservable inputs.
Level 1 Level 2 Level 3 Total As of 31 March 2017 000 000 000 000 Investments held at fair value through profit or loss 1,127,087 30,475 1,157,562 Derivatives: put and call options short 282 282 Derivatives: put and call options long 1,191 1,191 Derivatives: OTC swaps 34,410 34,410 Financial instruments measured at fair value 1,127,087 35,319 30,475 1,192,881 As at 31 March 2017, the put and call options and equity swaps have been classified as Level 2.
As at 31 March 2017, the five debt investments included in the portfolio on pages 8 and 9 have been classified as Level 3.
All level 3 positions have been valued using the estimated fair values as provided by counterparties.
Level 1 Level 2 Level 3 Total As of 31 March 2016 000 000 000 000 Investments held at fair value through profit or loss 888,754 16,717 905,471 Derivatives: put and call options short 744 744 Derivatives: put and call options long 353 353 Derivatives: OTC swaps 30,199 30,199 Financial instruments measured at fair value 888,754 29,808 16,717 935,279 As at 31 March 2016, the put and call options and equity swaps have been classified as Level 2.
As at 31 March 2016, the two securitised debt investments Creganna-Tactx Medical Second Lien Loan FRN 20 11 22 and Merrimack Pharmaceuticals Second Lien Loan 11.5% 15 12 22 have been classified as Level 3.
Both positions have been valued using the estimated fair values as provided by counterparties.
viii Capital management policies and procedures The Companys capital management objectives are to ensure that it will be able to continue as a going concern and to maximise the income and capital return to its equity shareholders through an appropriate level of gearing or leverage.
The Boards policy on gearing and leverage is set out on page 7.
As at 31 March 2017, the Company had a leverage percentage of 16.9% 2016: 14.0%.
Worldwide Healthcare Trust PLC Annual Report for the year ended 31 March 2017 69
